# OnCo record danny-rischin (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/danny-rischin/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "danny-rischin" ;
  schema:name "Danny Rischin"@en ;
  schema:description "Melbourne oncologist who led C-POST, the trial that showed cemiplimab after surgery and radiotherapy cuts recurrence in high-risk cutaneous squamous-cell carcinoma."@en ;
  schema:url <https://onco.cc/people/danny-rischin/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "skin", "head-and-neck", "immunotherapy", "trialist" ;
  schema:jobTitle "Medical oncologist and Director of Medical Oncology, Peter MacCallum Cancer Centre" ;
  schema:sameAs <https://orcid.org/0000-0002-3368-0386> ;
  onco:cancers <https://onco.cc/cancers/advanced-cutaneous-scc/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/skin-cancer/> ;
  onco:institutions <https://onco.cc/institutions/peter-mac/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-c-post-adjuvant-cemiplimab-nejm-2025/> ;
  schema:affiliation <https://onco.cc/institutions/peter-mac/> .